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Abstract: Colon leakage score (CLS) was introduced as a clinical tool to predict anastomotic leakage
(AL) in patients who underwent left-sided colorectal surgery, but its clinical validity has not been
widely studied. We evaluated the clinical utility of CLS and developed a modified CLS (m-CLS).
In total, 566 patients who underwent left-sided colorectal surgery were enrolled and categorized
into training (n = 396) and validation (n = 170) sets via random sampling. Using CLS variables,
the least absolute shrinkage and selection operator (LASSO) regression model was applied for variable
selection and predictive signature building in the training set. The model’s performance was validated
in the validation set. The predictive powers of m-CLS and CLS were compared by the area under the
receiver operating characteristic (AUROC) curve in the overall group. Twenty-three AL events (4.1%)
were noted. The AL group had a significantly higher mean CLS than the No Leakage group (12.5
vs. 9.6, p = 0.001). Five clinical variables were selected and used to generate m-CLS. The predictive
performance of m-CLS was similar in training and validation sets (AUROC 0.838 vs. 0.803, p = 0.724).
In the overall set, m-CLS was significantly predictive of AL and performed better than CLS (AUROC
0.831 vs. 0.701, p = 0.008). In conclusion, LASSO-model-generated m-CLS could predict AL more
accurately than CLS.
Keywords: anastomotic leakage; rectal neoplasms; colorectal cancer; area under the curve; LASSO
1. Introduction
Anastomotic leakage (AL) is one of the most serious and devastating post-operative complications
of colorectal cancer surgery. AL has an incidence of 3–27% and a mortality rate of 25–37% [1–6]. It is
an adverse risk factor for long-term outcomes in these patients [7–10]. Securing an adequate blood
supply for the remaining bowel and a tension-free anastomosis are the most important principles of
AL reduction. Splenic flexure mobilization and low ligation, which preserve the left colic artery for the
remaining bowel, are procedures often performed for this purpose in a left-sided colorectal surgery,
although there is still some debate on its role [11,12]. An air leak test and the use of an indwelling
drainage tube are additional ways of potentially reducing AL [13–18].
In addition, the surgeon often has to decide whether to pursue either a protective ileostomy or
a colostomy. It is believed that while diversion itself cannot diminish AL, it can reduce the severity
of AL-induced complications [19,20]. However, it can cause morbidity, which cannot be ignored.
The complications during diversion, especially in diverting ileostomy, include dehydration and
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stoma prolapse, which occur in 11–43% of cases [21–25]. Even at the time of reversing the stoma,
the complication rate was reported as 14–33% and, in several cases, the permanent reversal of diversion
is impossible [21,26–30]. Therefore, the decision to perform a diversion must be made prudently;
however, to date, there have been no reliable indications available.
The colon leakage score (CLS) was initially suggested to predict the risk of AL in left-sided
surgeries by Dekker and colleagues in 2011 [31]. The CLS was composed of several clinical parameters,
based on previous studies, and was calculated as a numeric score ranging from 0 to 43. Although
few studies have validated the efficacy of CLS in patients with colorectal cancer [32,33], the clinical
significance of its use has undergone limited evaluation.
Recently, it was reported that the surgeon perception of treatment risk and benefit varied
significantly, and a risk assessment or a risk calculator could lead surgeons to more accurate judgements
of operative risks [34,35]. In the case of predicting AL for 83 patients with colon cancer, a simple
anastomotic leak calculator was highly predictive of AL (area under the receiver-operating characteristic
curve (AUROC), 0.84), as unlike the surgeon’s estimation (AUROC, 0.4) [36]. Accurate and clinically
useful prediction models are gaining importance. Recently machine learning algorithms have been
introduced that are actively applied in the clinical decision-making process [37,38]. We hypothesized
that there might be some room to improve the predictive power of CLS by applying these algorithms.
Therefore, the aim of this study was to assess the clinical implications of the CLS in our patients
and to improve the predictive power of this model.
2. Materials and Methods
2.1. Patients
The study group consisted of consecutive patients who underwent left-sided colorectal cancer
surgeries at the Gangnam Severance Hospital, Yonsei University College of Medicine (Seoul, Republic
of Korea) between August 2006 and March 2013. The patients were identified retrospectively from a
prospectively-maintained database. The inclusion criterion was all patients with left-sided colorectal
cancer (including left colon, sigmoid colon, rectosigmoid colon and rectum cancers) treated with a
curative intent, irrespective of an elective or emergent surgery, in whom a primary anastomosis was
performed. The exclusion criteria were patients who did not undergo primary anastomosis or R2
resection and patients with missing information, in which case the variables composing CLS could
not be determined. This study was approved by Institutional Review Board of Gangnam Severance
Hospital, Yonsei University College of Medicine (Seoul, Republic of Korea) (approval No. 3-2018-0326).
Informed consent was waived for this retrospective study.
2.2. Surgery and Diagnosis of AL
Each of the enrolled patients underwent a different type of surgery based on the location of the
tumor. A left hemicolectomy was done for tumors in the left or sigmoid colon, while an anterior
resection or a low anterior resection was done for tumors in the distal or rectosigmoid colon. Patients
with rectal cancer underwent a low anterior resection, coloanal anastomosis, or an intersphincteric
resection. Patients who underwent a Hartmann operation or an abdominoperineal resection were
excluded. The surgeries were performed using a consistent surgical principle. The standard surgical
modality for patients with rectal cancer was either a total mesorectal excision or a tumor-specific
mesorectal excision. For left-sided tumors, at the discretion of the surgeon, the inferior mesenteric
artery was ligated at the level of its origin or just below the left colic artery. The decision to create a
diverting ileostomy or colostomy was left to the discretion of the surgeon.
AL was initially suspected from clinical manifestations such as abdominal pain, fever, and discharge
of pus or bowel contents through the abdominal drain causing peritonitis. It was confirmed by either
laparotomy or imaging studies, such as computed tomography (CT) and X-ray.
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2.3. Clinical Variables Used in Generating Modified CLS
CLS is a scoring system suggested by Dekker and colleagues [27]. The system combines the
following 11 risk factors for AL: age, gender, the American Society of Anesthesiologists (ASA) grade,
body mass index, history of intoxication, history of neoadjuvant therapy, history of emergency surgery,
distance of anastomosis to the anal verge, requirement of additional procedures, amount of blood
loss, and duration of the surgical procedure. Each variable is scored numerically, and the risk of AL is
predicted on the basis of the total score, which ranges between 0 and 43 in the CLS model.
We collected data (used in calculating CLS) from our group, and only these variables were used
in generating a new algorithm. In this study, the least absolute shrinkage and selection operator
(LASSO) regression model was used to generate the predictive model [39]. In this model, the regression
coefficients penalize the size of the parameters, which can remove unimportant variables. The LASSO
regression model was applied for feature selection and predictive signature building, called the
modified CLS (m-CLS). LASSO regression shrinks the coefficient estimates toward zero, with the
degree of shrinkage dependent on an additional parameter, λ. To determine the optimal values of λ,
a 10-time cross-validation was used, and we chose λ via the minimum criteria.
Our patients were divided into the following two groups via computer-generated random
sampling; the training set and the validation set. The prediction model (m-CLS) was developed in the
training set and validated in the validation set. The performance of the m-CLS, in comparison to the
CLS, was measured by the AUROC analysis in the overall (training and validation) set.
2.4. Statistical Analysis
All statistical analyses were performed using IBM SPSS version 23.0 (IBM Corp., Armonk, NY,
USA) and R version 3.5.1 (R-project, Institute for Statistics and Mathematics, Vienna, Austria). AUROC
was used to determine the predictive value of CLS and m-CLS. The predictive value, estimated by
AUROC, was classified as follows: >0.9: excellent, 0.8–0.9: good, 0.7–0.8: fair, 0.6–0.7: poor, 0.5–0.6:
very poor. The optimal cut-off values were determined at the maxima of the Youden’s index and
accuracy [40]. Categorical variables were analyzed using the Chi-square or the Fisher’s exact test,
and continuous variables were analyzed using the Student’s t test. A p value < 0.05 was considered to
indicate significance.
3. Results
3.1. Patient Characteristics According to the Anastomotic Leakage
A total of 784 patients who underwent left-sided colorectal cancer surgeries were identified in
the database, of which 566 were ultimately included in the analysis. Baseline patient characteristics
according to the AL are shown in Table 1. While the overall AL rate was 4.1% (n = 23), the rate of low
anastomosis level was significantly higher in the AL group. Alcohol intake and diversion rate were
significantly higher in patients who had an AL versus those who did not. Mean CLS was significantly
higher in the AL group than in the No Leakage group (12.5 vs. 9.6, p = 0.001) (Figure 1).
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Table 1. Comparison of patient characteristics between AL group and No leakage group.
AL (n = 23)
n (%)
No Leakage
(n = 543) n (%) P
Age (years) Mean ± SD 60.8 ± 12.6 62.1 ± 10.9 0.574
Gender Male 17 (73.9) 346 (63.7) 0.438
Female 6 (26.1) 197 (36.3)
ASA grade a I 16 (69.6) 272 (50.1) 0.076 b
II 4 (17.4) 226 (41.6)
III 3 (13) 44 (8.1)
IV 0 1 (0.2)
BMI c (kg/m2) Mean ± SD 23.7 ± 3.5 23.4 ± 3.2 0.672
Smoking (any) 10 (43.5) 185 (34.1) 0.375
Alcohol (3U/day) 9 (39.1) 109 (20.1) 0.036 b
Steroids (present use,excluding inhaler) 2 (8.7) 2 (0.4) 0.009
b
Neoadjuvant therapy Radiotherapy 0 3 (0.6) >0.999 b
Chemoradiation 5 (21.7) 69 (12.7) 0.207 b
Emergency surgery Obstruction 4 (17.4) 100 (18.4) >0.999 b
Bleeding 0 8 (1.5) >0.999 b
Perforation 0 12 (2.2) >0.999 b
Distance of anastomosis to
anal verge (cm) <5 10 (43.5) 110 (20.3) <0.001
b
5–10 12 (52.2) 186 (34.3)
>10 1 (4.3) 247 (45.5)
Additional procedures 1 (4.3) 139 (25.6) 0.023
Blood loss (mL) Mean ± SD 282.6 ± 280.6 287.9 ± 455.5 0.933
Duration of operation (min) Mean ± SD 294.5 ± 76.8 272.6 ± 104.8 0.322
Diversion 2 (8.7) 4 (0.7) 0.021 b
Tumor location Colon 1 (4.3) 249 (45.9) <0.001
Rectum 22 (95.7) 294 (54.1)
CLS d Mean ± SD 12.5 ± 3.6 9.6 ± 4.2 0.001
Surgery type Open 7 (30.4) 175 (32.2) 0.458
Laparoscopy 8 (34.8) 239 (44)
Robot 8 (34.8) 129 (23.8)
AL: anastomotic leakage; SD: standard deviation; a: American society of anesthesiology; b: Fisher’s exact test; c:
Body mass index; d: Colon leakage score.J. Clin. Med. 2019, 8, x FOR PEER REVIEW 4 of 11 
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3.2. Comparison of Patient Characteristics between the Training Set and the Validation Set
By computer-generated random sampling, the patients were divided into the training set
(396 patients) and the validation set (170 patients). There was no difference in the incidence of
AL between the two sets (4.3% vs. 3.5%, p = 0.850). No difference in the clinicopathologic parameters
were detected between the two groups (Table 2).
Table 2. Patient demographics and operative outcomes between the training set and the validation set.
Training Set
(n = 396) n (%)
Validation Set
(n = 170) n (%) P
Age (years) Mean ± SD 62.5 ± 10.8 61.2 ± 11.5 0.186
Gender Male 251 (63.4) 112 (65.9) 0.637
Female 145 (36.6) 58 (34.1)
ASA grade a I 195 (49.2) 93 (54.7) 0.417
II 169 (42.7) 61 (35.9)
III 31 (7.8) 16 (9.4)
IV 1 (0.3) 0
BMI b (kg/m2) Mean ± SD 23.6 ± 3.1 23.1 ± 3.3 0.102
Smoking (any) 135 (34.1) 60 (35.3) 0.857
Alcohol (3U/day) 75 (18.9) 43 (25.3) 0.111
Steroids (present use,excluding inhaler) 3 (0.8) 1 (0.6) >0.999
Neoadjuvant therapy Radiotherapy 1 (0.3) 2 (1.2) 0.449
Chemoradiation 51 (12.9) 23 (13.5) 0.941
Emergency surgery Obstruction 76 (19.2) 28 (16.5) 0.517
Bleeding 7 (1.8) 1 (0.6) 0.446 b
Perforation 10 (2.5) 2 (1.2) 0.482
Distance of anastomosis to
anal verge (cm) <5 85 (21.5) 35 (20.6) 0.575
5–10 143 (36.1) 55 (32.4)
>10 168 (42.4) 80 (47.1)
Additional procedures 96 (24.2) 44 (25.9) 0.758
Blood loss (mL) Mean ± SD 280.3 ± 421.4 304.9 ± 510.2 0.580
Duration of operation (min) Mean ± SD 275.9 ± 109.5 267.6 ± 89.1 0.345
Diversion 3 (0.8) 3 (1.8) 0.532
Tumor location Colon 206 (52) 89 (52.4) >0.999
Rectum 190 (48) 81 (47.6)
CLS c Mean ± SD 9.8 ± 4 9.7 ± 4.6 0.942
Anastomotic leakage 17 (4.3) 6 (3.5) 0.850
Surgery type Open 131 (33.1) 51 (30) 0.656
Laparoscopy 168 (42.4) 79 (46.5)
Robot 97 (24.5) 40 (23.5)
SD: Standard Deviation; a: American society of anesthesiology; b: Body mass index; c: Colon leakage score.
3.3. Feature Selection and Generation of Modified CLS
Of the clinical variables included in the CLS model, five potential predictors (based on the
patients in the training set) were features with non-zero coefficients in the LASSO logistic regression
model. These five parameters consisted of distance of anastomosis to anal verge, ASA grade 2, alcohol
(3U/day), steroid (present use, excluding inhaler), and additional procedures. The combination of
these parameters were presented as the modified CLS (Supplementary Figure S2). Distributions of the
m-CLS in the overall set are given in the Supplementary File.
3.4. AUROC Comparison
There was no difference in the AUROC for m-CLS between the training and the validation sets
[0.838 (95%CI: 0.774–0.902) vs. 0.803 (95%CI: 0.624–0.983), p = 0.724] (Figure 2). From the analysis of
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the overall set, the m-CLS was significantly predictive of AL, and better than the CLS [AUROC: 0.831
(95%CI: 0.767–0.896) vs. 0.701 (95%CI: 0.616–0.787), p = 0.008] (Figure 3). The sensitivity, specificity,
positive predictive value (PPV), negative predictive value (NPV), and accuracy based on the specific
cut-off values of the m-CLS and CLS are shown in Supplementary Tables S1 and S2. The statistically
optimal cut-off value for the m-CLS was 0.055 (sensitivity: 0.957, specificity: 0.718, PPV: 0.126, NPV:
0.997, and accuracy: 0.728), and for the CLS was 8.5 (sensitivity: 0.913, specificity: 0.433, PPV: 0.064,
NPV: 0.992, and accuracy: 0.452).
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4. Discussion
This study demonstrated that m-CLS, which was developed using the LASSO logistic regression
model derived from the clinical variables incorporated in the CLS, provides a more accurate prediction
for the risk of AL than the CLS, in patients who underwent left-sided colorectal cancer surgeries.
The accuracy of CLS was initially reported to be quite high [AUROC, 0.95 (95% CI, 0.89–1.00)] [31].
Two studies performed subsequently to validate the CLS gave relatively good results, with the AUROC
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being 0.965 (95% CI, 0.913–1.00) and 0.80 (95% CI, 0.618–0.982) [32,33]. In this study, although the mean
CLS was significantly higher in the AL group than in the No Leakage group, the predictive strength of
CLS (AUROC 0.701) was not as high as was anticipated. Although it is difficult to reveal the exact
reasons for this discrepancy, several factors may have been involved. An important CLS variable is
the distance of anastomosis to the anal verge. This is a well-known clinical variable associated with
the occurrence of AL in patients diagnosed with rectal cancer [41]. Nevertheless, it is sometimes
difficult to accurately define the level of anastomosis, especially for left or sigmoid colon cancers in
retrospective studies. In our study, since 27.8% of the patients were excluded, mainly due to a lack of
this information, it may have led to a selection bias. Another factor that can be speculated upon is the
low rate of patients with preoperative steroid use in our cohort. Although there is still some debate
on the real impact of steroid use on AL risk and the definition of steroid use is variable, in previous
prospective or retrospective studies, its rate in the pretreatment periods in colorectal surgeries ranged
from 2.2 to 5.3% [42–46]. In this study, only four patients (0.7%) were classified as using steroids,
although a lower rate of steroid use might be the specific characteristic of our patients. Considering the
potential contribution of steroid use in AL occurrence, this relatively low rate seems to have worked in
interrupting the accurate prediction of CLS.
Our study used the LASSO logistic regression model to determine whether the predictive power
of m-CLS could be increased. The advantage of LASSO is that those variables from the patient data that
are strongly associated with the prediction can be selected. Based on the comparison using ROC curves,
we were able to confirm that the newly developed AL classifier (m-CLS) has a better predictive power
than the CLS. Several AL risk prediction models have been developed for patients with colorectal
cancer [33,47–50]. These predictive models would ultimately help surgeons decide whether to perform
a diversion indirectly, by estimating a possibility of AL. However, neither our study nor previous
studies could elucidate how these predictions would actually help reduce the AL rate in patients with
colorectal cancer. Recently, a simple AL risk calculator was shown to have a better predictive power
for AL than the surgeon’s estimation [36]. However, that study had several limitations, in that the
number of included patients was relatively small and they all had colon cancer. Thus, we cannot
confirm whether this calculator has any significant predictive role for patients with rectal cancer [36].
It is unclear whether using these predictive scoring systems rather than relying on the surgeon’s own
experience to decide upon a diverting ileostomy would actually help in clinical practice. Further
well-designed clinical trials are needed to confirm the validity of such predictive models.
There were several limitations in this study. This study is retrospective in nature, resulting in
missing data that could result in a selection bias. In addition, this study was done in a single center
using a relatively small sample size for prediction. The overall AL rate in our study was relatively
low, thus it is questionable whether the predictive model we developed can be applied to other
groups having higher AL rate as well. Our model was generated using the clinical outcomes of East
Asian people. Since the patients’ characteristics differ with each hospital, as well as race, the risk
prediction model cannot be applied globally. Although we tried to validate our model using our
internal validation set, to overcome this limitation fundamentally, it requires external validation using
an independent different population before it can be accepted for use in diverse situations. This study
included patients who underwent left-sided colorectal cancer surgeries. AL is generally more frequent
in patients with rectal cancer than in those with colon cancer. Therefore, the need for developing a
predictive model for patients with rectal cancer is even greater. In our study, when we confined the
subgroup to only patients with rectal cancer, the AUROC was significantly higher in the m-CLS model
than in the CLS model [69.1 (95% CI, 58.2–79.9) vs. 54.4 (95% CI, 42.4–66.4), p = 0.037]. However,
its overall accuracy in both predictive models was not satisfactory, demonstrating that a different
predictive model for rectal cancer is required.
J. Clin. Med. 2019, 8, 1450 8 of 11
5. Conclusions
This study confirmed that m-CLS provides a more accurate prediction of AL than CLS in patients
who have undergone left-sided colorectal cancer surgeries. Further research on the clinical efficacy of
this prediction model in AL reduction is required. Besides, a prediction model specialized for patients
with rectal cancer is warranted.
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